Dogwood Therapeutics Investor Relations Material

Dogwood Therapeutics Inc. is a biopharmaceutical company focused on the discovery and development of innovative therapies targeting complex diseases. Utilizing advanced scientific research and proprietary technology platforms, the company aims to address unmet medical needs across therapeutic areas such as oncology, immunology, and infectious diseases. Dogwood Therapeutics is engaged in preclinical and clinical research, partnering with healthcare organizations and research institutions to advance potential treatments. The company is headquartered in Cambridge, Massachusetts, and its shares are listed on the NASDAQ.